Ritedose unveils state-of-the-art distribution and logistics facility at Ritedose Performance Park  

New facility expands Ritedose’s capabilities to handle well over 2 billion doses per year 

The Ritedose Corporation, a leading pharmaceutical  manufacturer specializing in Blow-Fill-Seal (BFS) technology, today unveiled its new distribution and logistics facility at Performance Park during a ribbon-cutting ceremony. The grand opening  event included Ritedose CEO Jody Chastain, state and county officials, community leaders, and  key partners in the life sciences ecosystem.

At the heart of Performance Park is a new 225,000-square-foot central distribution and logistics  center that expands Ritedose’s capabilities to handle well over 2 billion doses per year. The new  facility is part of a multiphase $81M investment that has created an additional 100 new jobs. This major investment reflects Ritedose’s ongoing commitment to innovation, workforce  development, and the future of both South Carolina’s $25.7 billion life sciences industry and the  country’s.

“This purpose-built facility marks the next phase of growth for Ritedose Performance Park,” said  Chastain. “It expands our capabilities to handle logistics and distributions of well over 2 billion  doses per year. However, we weren’t just thinking about growing square footage, labs or  equipment when we started planning this facility—our thoughts were also on growing our people  and supporting our community. We’re a different kind of company that is deeply rooted in our  purpose and driven by passion to make a difference in the lives of others, and we’re just getting  started.”

Other highlights of 1150 Performance Parkway include:

• The first LEED-certified building on Ritedose’s campus, demonstrating the Company’s  commitment to environmental stewardship
• A half-mile walking path through nine acres of preserved wetlands, underscoring  Ritedose’s focus on employee health and wellness
• An $11M lab inside the facility (construction to begin in fall 2025), allowing Ritedose to  assist more early-stage companies in developing therapeutics and getting them to  market efficiently
• A 150-seat training facility, designated as the “Ritedose Center of Excellence,” designed  to enhance employee professional development and offer personal growth opportunities  through specialized classes on personal finance, health and wellness, among others
• Two outdoor murals by local Columbia artist, Ija Charles, depicting Ritedose core values:  “Work for the Greater Good” and “See Beyond Ourselves”

• This year marks Ritedose’s 30th year, and the company has been making significant  advancements both operationally and for the community:
• A 2024 expansion of high-speed Blow-Fill-Seal lines that added 180-million-unit dose  capacity for ophthalmic and respiratory medications
• The addition of a seventh Syntegon packaging line that doubled capacity to package  individually wrapped vial medications
• Becoming the manufacturing partner of choice for Verona Pharma’s new COPD drug  Ohtuvayre
• Securing several FDA approvals for new COPD and asthma medications—helping  address a national shortage of Albuterol
• Launching “1000 Hours of Purpose” (in collaboration with United Way of the Midlands), donating 1,000 hours of employee time to support various local organizations that are  addressing basic human needs like hunger and housing
• Raising $66,000 in continued support of the American Heart Association’s Field Day  events
• Donating 1 Million (1M) doses to the national charitable medication distributor,  Dispensary of Hope, to provide essential respiratory medications for low-income and  chronically ill patients across the country.

About The Ritedose Corporation  

Ritedose is the largest sterile contract development manufacturing organization (CDMO) in the  US specializing in sterile Blow Fill Seal (BFS) technology that ensures sterile, consistent, and  safe unit dose delivery. The company’s process guides the development of molecules from  clinical trials to commercialization of branded and generic inhalation and ophthalmic  medications. With a focus on quality, innovation, and customer satisfaction, Ritedose partners  with leading pharmaceutical companies to deliver safe, effective, and reliable medications that  improve patient outcomes. Ritedose: Passion and Precision with a Purpose. For more  information visit Ritedose.com